Published in Zh Mikrobiol Epidemiol Immunobiol on January 01, 1972
[Correction of intestinal dysbacteriosis with biological preparations in acute leukemia]. Probl Gematol Pereliv Krovi (1981) 0.84
[Lysozyme in the overall therapy of patients with burn trauma]. Antibiotiki (1975) 0.77
[Local immunity of the upper respiratory tract in patients with acute leukemia]. Vopr Onkol (1984) 0.77
[Study of the microbe factor in the process of plasma fractionation and several problems of pyrogenicity of blood preparations]. Probl Gematol Pereliv Krovi (1970) 0.75
[Use of prodigiozan in the complex therapy of burns]. Antibiotiki (1971) 0.75
[Microbial factor in the complications of acute leukemia]. Probl Gematol Pereliv Krovi (1972) 0.75
[Cytomegalovirus infection after bone marrow transplantation]. Gematol Transfuziol (1986) 0.75
[Use of lysozyme for prevention and treatment of infectious complications in leukemic patients]. Probl Gematol Pereliv Krovi (1977) 0.75
[Cytomegalovirus infection in leukemia]. Gematol Transfuziol (1985) 0.75
[Comparison of the morphofunctional properties of the cells obtained in the process of plasmapheresis and cytapheresis on the RK-0.5 (USSR) and Aminco (USA) apparatus]. Gematol Transfuziol (1983) 0.75
[Microbiological characteristics of intestinal dysbacteriosis in acute leukemia]. Probl Gematol Pereliv Krovi (1978) 0.75
[Immunoglobulins in acute leukemia]. Probl Gematol Pereliv Krovi (1976) 0.75
[Use of antibiotics in burns in dogs]. Antibiotiki (1969) 0.75
[Experimental studies on aerosols of lysozyme and ecmonovocillin]. Antibiotiki (1965) 0.75
[On the interaction of the body's specific and non-specific defense factors in the process of active immunization with staphylococcal anatoxin]. Zh Mikrobiol Epidemiol Immunobiol (1968) 0.75
[Period of preservation of the functional properties of granulocytes isolated by blood cell separation]. Probl Gematol Pereliv Krovi (1982) 0.75
[Chronic lympholeukemia--a disease of immunologic insufficiency]. Ter Arkh (1972) 0.75
[Characteristics of microbial autoflora in acute leukemia treated under conditions of aseptic hospital ward]. Probl Gematol Pereliv Krovi (1978) 0.75
[Use of skin antiseptics for treatment of the hands of exfusionists and ulnar flexures of donors]. Probl Gematol Pereliv Krovi (1968) 0.75
[A study of the activity of antimicrobial cellulose fibers for the purpose of using them for sterilizing air]. Zh Mikrobiol Epidemiol Immunobiol (1969) 0.75
[Relationship between phagocytosis and sensitization to bacterial allergens in patients with chronic bronchitis]. Lab Delo (1983) 0.75
[Study of the action of some antibiotics in combination with the new sulfanilamide compound sulfapyridazine during the acute course of experimental staphylococcal infection]. Antibiotiki (1966) 0.75
[Changes in hematopoiesis in Rausher virus resistant mice under the combined effects of this virus and L-form microorganisms isolated from patients with acute leukosis]. Vopr Onkol (1974) 0.75
[Effect of cholinergic factors on the state of immunogenesis in animals with paroxysmal nocturnal hemoglobinuria-like hemolytic anemia]. Probl Gematol Pereliv Krovi (1980) 0.75
[Secretory IgA and serum immunoglobulins as indices of the local immunity of the intestinal mucosa in acute leukemias]. Probl Gematol Pereliv Krovi (1981) 0.75
[Experimental infection of mice with bacterial L forms against a background of immunodepressants]. Zh Mikrobiol Epidemiol Immunobiol (1974) 0.75
[Characteristics of intestinal microflora in patients with acute leukemia]. Probl Gematol Pereliv Krovi (1978) 0.75
[Identification and differentiation of nonspecific lymphadenopathies in the polyclinic]. Ter Arkh (1987) 0.75
[Sterilization of plastic sacs containing blood preservative by radiation-thermal method]. Probl Gematol Pereliv Krovi (1974) 0.75
[Experience in using antimicrobial fabric articles in the surgical and hematological clinics of the Central Institute of Hematology and Blood Transfusion]. Probl Gematol Pereliv Krovi (1978) 0.75
[Seasonal changes in the microflora of skin and pharynx as an index of immunity in donors]. Zh Mikrobiol Epidemiol Immunobiol (1974) 0.75
[Change in the morphological and biological properties of microorganisms exposed to toxic serums from leukemic patients]. Zh Mikrobiol Epidemiol Immunobiol (1974) 0.75
[Immunological and microbiological parallels in pneumonia complicating leukemia]. Klin Med (Mosk) (1973) 0.75
[Immunochemical analysis of the hydrosoluble antigens of the BCG vaccine and alt-tuberculin]. Probl Tuberk (1967) 0.75
[Immunoglobulins and nonspecific immunity factors in leukemias]. Vopr Onkol (1978) 0.75
[Immunoglobulin and lysozyme content in the intestines during correction of the dysbacteriosis of acute leukemia patients]. Vopr Onkol (1981) 0.75
[The significance of E. coli endotoxin in the etiology of burn autointoxication]. Patol Fiziol Eksp Ter (1970) 0.75
[Clinical laboratory manifestations of cytomegalovirus infection in patients with leukemias]. Gematol Transfuziol (1988) 0.75
[Pyrogenicity of blood preparations]. Zh Mikrobiol Epidemiol Immunobiol (1971) 0.75
[Use of different nutrient media for the isolation of hemocultures]. Lab Delo (1980) 0.75
[Study of the effect of some antibiotics in combination with the new sulfanilamide preparation sulfapyridazine in experimental chronic staphylococcal infection]. Antibiotiki (1966) 0.75
[Intestinal dysbacteriosis as a cause of patient endogenous infection]. Sov Med (1981) 0.75
[Immunosuppressive effect of cytostatics]. Probl Gematol Pereliv Krovi (1980) 0.75
[Cholinergic mechanisms in the development of cytopenia as a preleukemic syndrome (the problems of pathogenesis, diagnosis and therapy)]. Voen Med Zh (1989) 0.75
[Formation of L-form bacteria in patients with leukemia]. Probl Gematol Pereliv Krovi (1971) 0.75
[Isolation and identification of microbial agents from the bone marrow and blood of patients with acute leukemia]. Zh Mikrobiol Epidemiol Immunobiol (1971) 0.75
[Thioglycolic medium for control of sterility of preserved blood and its derivatives]. Probl Gematol Pereliv Krovi (1978) 0.75
[Chemotherapy of experimental staphylococcal infection with antibiotics in combination with antistaphylococcal gamma-globulin]. Antibiotiki (1969) 0.75
[Functional properties of granulocytes obtained by automatic cytopheresis]. Probl Gematol Pereliv Krovi (1981) 0.75
[Experience in the use of prodigiozan in leukemia]. Klin Med (Mosk) (1970) 0.75
[Treatment and prevention of experimental pneumonias, caused by L forms of bacteria]. Zh Mikrobiol Epidemiol Immunobiol (1975) 0.75
[Comparative analysis of immunity in acute leukemia treated according to various chemotherapeutic programs]. Probl Gematol Pereliv Krovi (1980) 0.75
[Effect of lysozyme on the protective function of microphases and macrophages]. Antibiotiki (1967) 0.75
[State of some immunity indices in various diseases of staphylococcal etiology]. Zh Mikrobiol Epidemiol Immunobiol (1971) 0.75
[State of natural immunity in paroxysmal nocturnal hemoglobinuria]. Probl Gematol Pereliv Krovi (1980) 0.75
[Changes in the biocenosis of the mouth as an indication of intestinal dysbacteriosis]. Lab Delo (1983) 0.75
[Content of lysozyme in the tissue of tonsils and adenoids, administered by electrophoresis]. Zh Ushn Nos Gorl Bolezn (1970) 0.75
[Effect of prodigiozan on the course of burns in dogs]. Antibiotiki (1970) 0.75
[Provision of aseptic conditions in preparations of blood]. Probl Gematol Pereliv Krovi (1968) 0.75
[Neutropenia and neutrophil antibodies in children]. Gematol Transfuziol (1985) 0.75
[Use of antimicrobial unwoven filter materials for sterilization of air, used for compression and drying of plasma]. Probl Gematol Pereliv Krovi (1968) 0.75
[Bacteria and toxic properties of blood in leukemia]. Probl Gematol Pereliv Krovi (1975) 0.75
[Myeloperoxidase activity and the digestive capacity of the neutrophils in acute myeloblastic leukemia]. Probl Gematol Pereliv Krovi (1979) 0.75
[Hereditary angioneurotic edema (its pathogenesis, clinical aspects, diagnosis, treatment)]. Ter Arkh (1985) 0.75
[State of immunity in patients with hemoblastosis during cytomegalovirus infection]. Gematol Transfuziol (1988) 0.75
[Experimental data on a study of the bacterial factor in acute leukemia]. Patol Fiziol Eksp Ter (1970) 0.75
[Use of aerosol bactericidal flasks for air decontamination]. Probl Gematol Pereliv Krovi (1968) 0.75
[Effect of blood components in hemotherapy on the factors of anti-infectious protection in patients with acute leukemias]. Gematol Transfuziol (1988) 0.75
[Change of factors of natural immunity in acute leukemia]. Probl Gematol Pereliv Krovi (1974) 0.75
[Natural immunity indices in dysbacteriosis]. Probl Gematol Pereliv Krovi (1979) 0.75
[Effect of antistaphylococcal gamma globulin in experimental staphylococcal infection]. Zh Mikrobiol Epidemiol Immunobiol (1971) 0.75
[Cryopreservation of granulocytes using "Leukocryodmac" solution]. Gematol Transfuziol (1986) 0.75
[The effect of lysozyme on the phagocytic capacity of leukocytes in experiments in vitro]. Antibiotiki (1966) 0.75
[Intraleukocytic lysozyme in acute leukemias]. Probl Gematol Pereliv Krovi (1980) 0.75
[Gamma-globulin from the plasma of donors actively immunized with staphylococcus anatoxin]. Probl Gematol Pereliv Krovi (1969) 0.75
[Significance of microbial agents in the development of toxemia in patients with leukemia]. Probl Gematol Pereliv Krovi (1975) 0.75
[Use of antistaphylococcal placental gamma-globulin in newborns and young children with staphylococcal diseases]. Vopr Okhr Materin Det (1970) 0.75
[Long-term storage of leukocytes from patients with chronic myeloleukemia using the Leukocryodmac solution]. Gematol Transfuziol (1988) 0.75
[Change in natural immunity factors in leukopenias and leukocytoses of unclear genesis]. Probl Gematol Pereliv Krovi (1979) 0.75
[Immunobiological and microbiological characteristics of pneumonia during leukemia]. Probl Gematol Pereliv Krovi (1971) 0.75
[Antistaphylococcal placental gamma-globulin]. Probl Gematol Pereliv Krovi (1969) 0.75
[Digestive capacity of neutrophils in leukoses]. Lab Delo (1975) 0.75
[Effectiveness of antistaphylococcal gamma globulin in treatment of infectious complications of acute leukemia]. Ter Arkh (1975) 0.75
[State of the oral tissues in hemoblastosis patients and the characteristics of preparing them for orthodontic treatment]. Stomatologiia (Mosk) (1986) 0.75
[Serological characteristics of atypical microbial agents isolated from the blood and bone marrow of patients with leukemia]. Probl Gematol Pereliv Krovi (1971) 0.75
[Sanitary condition of the aseptic ward in the hematological clinic (data of the microbiological study)]. Probl Gematol Pereliv Krovi (1978) 0.75
[Status of various parameters of anti-infectious immunity in patients with myelodysplastic syndromes]. Gematol Transfuziol (1991) 0.75
[Various indices of natural immunity after transfusion of packed leukocytes into hemoblastosis patients]. Gematol Transfuziol (1984) 0.75
[On the use of lysozyme and Ecmonovocillin in diseases of the upper respiratory tract]. Vestn Otorinolaringol (1969) 0.75
[Effect of the liposomal preparation aminophosphatide on erythrocyte lysis]. Vestn Akad Med Nauk SSSR (1990) 0.75
[Prediction of the sensitivity of chronic lympholeukemia patients to levamisole]. Gematol Transfuziol (1985) 0.75
[Infections in bone marrow recipients undergoing immunodepressive preparation]. Probl Gematol Pereliv Krovi (1982) 0.75
[The state of the complement system in infectious and neoplastic processes (review of the literature)]. Lab Delo (1989) 0.75